| 000 | 01158 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514072110.0 | ||
| 264 | 0 | _c20031009 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0214-0934 | ||
| 024 | 7 |
_a10.1358/dnp.2003.16.3.737958 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCollier, David A | |
| 245 | 0 | 0 |
_aPharmacogenetics in psychosis. _h[electronic resource] |
| 260 |
_bDrug news & perspectives _cApr 2003 |
||
| 300 |
_a159-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aClozapine _xadverse effects |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xgenetics |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 773 | 0 |
_tDrug news & perspectives _gvol. 16 _gno. 3 _gp. 159-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dnp.2003.16.3.737958 _zAvailable from publisher's website |
| 999 |
_c12603176 _d12603176 |
||